Literature DB >> 3840530

Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs.

D J Durand, R I Clyman, M A Heymann, J A Clements, F Mauray, J Kitterman, P Ballard.   

Abstract

We have created a totally synthetic, protein-free surfactant (Exosurf) composed of dipalmitoylphosphatidylcholine, hexadecanol, and tyloxapol. We studied the effects of endotracheal instillation of Exosurf on survival and pulmonary function of preterm lambs delivered at 131 to 133 days gestation (term 148 days). Exosurf treatment was compared with instillation of surface-active material prepared from lung lavages of adult sheep and with no instillation. Lambs were delivered by cesarean section, paralyzed, and mechanically ventilated. The Exosurf group survived longer (80% alive at 11 hours) than did the no instillation group (30% alive at 11 hours) (P less than 0.05). There were no statistically significant differences between the Exosurf and sheep surfactant groups. We conclude that Exosurf, a synthetic surfactant, produces significant improvement in survival and pulmonary function in preterm lambs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840530     DOI: 10.1016/s0022-3476(85)80416-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  14 in total

1.  Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B.

Authors:  Olivier Danhaive; Cheryl Chapin; Hart Horneman; Paola E Cogo; Philip L Ballard
Journal:  Pediatr Res       Date:  2014-10-31       Impact factor: 3.756

Review 2.  Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?

Authors:  Gautham K Suresh; Roger F Soll
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  Respiratory compliance in premature babies treated with artificial surfactant (ALEC).

Authors:  C J Morley; A Greenough
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 4.  Surfactant treatment for premature babies--a review of clinical trials.

Authors:  C J Morley
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 5.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

6.  Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons).

Authors:  H Maeta; D Vidyasagar; T Raju; R Bhat; H Matsuda
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 7.  Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.

Authors:  K L Dechant; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 8.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 9.  Paediatrics--Part I.

Authors:  B L Priestley; C J Harrison; M P Gerrard; A Gibson
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

10.  The role of surfactant in respiratory distress syndrome.

Authors:  Christopher Cheng-Hwa Ma; Sze Ma
Journal:  Open Respir Med J       Date:  2012-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.